Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VX-828 by Vertex Pharmaceuticals for Cystic Fibrosis: Likelihood of Approval
VX-828 is under clinical development by Vertex Pharmaceuticals and currently in Phase I for Cystic Fibrosis. According to GlobalData, Phase...